165 related articles for article (PubMed ID: 20440588)
1. Challenges and opportunities in establishing scientific and regulatory standards for assuring therapeutic equivalence of modified release products: workshop summary report.
Chen ML; Shah VP; Ganes D; Midha KK; Caro J; Nambiar P; Rocci ML; Thombre AG; Abrahamsson B; Conner D; Davit B; Fackler P; Farrell C; Gupta S; Katz R; Mehta M; Preskorn SH; Sanderink G; Stavchansky S; Temple R; Wang Y; Winkle H; Yu L
AAPS J; 2010 Sep; 12(3):371-7. PubMed ID: 20440588
[TBL] [Abstract][Full Text] [Related]
2. Challenges and opportunities in establishing scientific and regulatory standards for assuring therapeutic equivalence of modified-release products: workshop summary report.
Chen ML; Shah VP; Ganes D; Midha KK; Caro J; Nambiar P; Rocci ML; Thombre AG; Abrahamsson B; Conner D; Davit B; Fackler P; Farrell C; Gupta S; Katz R; Mehta M; Preskorn SH; Sanderink G; Stavchansky S; Temple R; Wang Y; Winkle H; Yu L
Eur J Pharm Sci; 2010 May; 40(2):148-53. PubMed ID: 20347972
[TBL] [Abstract][Full Text] [Related]
3. Challenges and opportunities in establishing scientific and regulatory standards for determining therapeutic equivalence of modified-release products: Workshop summary report.
Chen ML; Shah VP; Ganes D; Midha KK; Caro J; Nambiar P; Rocci ML; Thombre AG; Abrahamsson B; Conner D; Davit B; Fackler P; Farrell C; Gupta S; Katz R; Mehta M; Preskorn SH; Sanderink G; Stavchansky S; Temple R; Wang Y; Winkle H; Yu L
Clin Ther; 2010 Sep; 32(10):1704-12. PubMed ID: 21194592
[TBL] [Abstract][Full Text] [Related]
4. Harmonization of regulatory approaches for evaluating therapeutic equivalence and interchangeability of multisource drug products: workshop summary report.
Chen ML; Shah VP; Crommelin DJ; Shargel L; Bashaw D; Bhatti M; Blume H; Dressman J; Ducharme M; Fackler P; Hyslop T; Lutter L; Morais J; Ormsby E; Thomas S; Tsang YC; Velagapudi R; Yu LX
AAPS J; 2011 Dec; 13(4):556-64. PubMed ID: 21845486
[TBL] [Abstract][Full Text] [Related]
5. Harmonization of regulatory approaches for evaluating therapeutic equivalence and interchangeability of multisource drug products: workshop summary report.
Chen ML; Shah VP; Crommelin DJ; Shargel L; Bashaw D; Bhatti M; Blume H; Dressman J; Ducharme M; Fackler P; Hyslop T; Lutter L; Morais J; Ormsby E; Thomas S; Tsang YC; Velagapudi R; Yu LX
Eur J Pharm Sci; 2011 Nov; 44(4):506-13. PubMed ID: 21946259
[TBL] [Abstract][Full Text] [Related]
6. Bioavailability and Bioequivalence Aspects of Oral Modified-Release Drug Products.
Wang R; Conner DP; Li BV
AAPS J; 2017 Mar; 19(2):360-366. PubMed ID: 28004346
[TBL] [Abstract][Full Text] [Related]
7. The global bioequivalence harmonisation initiative: Report of EUFEPS/AAPS third conference.
Mehta M; Blume H; Beuerle G; Tampal N; Schug B; Potthast H; Jiang W; Wilson C
Eur J Pharm Sci; 2020 Aug; 151():105383. PubMed ID: 32473200
[TBL] [Abstract][Full Text] [Related]
8. Current challenges in bioequivalence, quality, and novel assessment technologies for topical products.
Yacobi A; Shah VP; Bashaw ED; Benfeldt E; Davit B; Ganes D; Ghosh T; Kanfer I; Kasting GB; Katz L; Lionberger R; Lu GW; Maibach HI; Pershing LK; Rackley RJ; Raw A; Shukla CG; Thakker K; Wagner N; Zovko E; Lane ME
Pharm Res; 2014 Apr; 31(4):837-46. PubMed ID: 24395404
[TBL] [Abstract][Full Text] [Related]
9. Summary report of second EUFEPS/AAPS conference on global harmonization in bioequivalence.
Chen ML; Blume H; Beuerle G; Mehta M; Potthast H; Brandt A; Schug BS; Ducharme M; Endrenyi L; Gallicano K; Schuirmann D; Welink J
Eur J Pharm Sci; 2019 Jan; 127():24-28. PubMed ID: 30342171
[TBL] [Abstract][Full Text] [Related]
10. Demonstrating Bioequivalence of Locally Acting Orally Inhaled Drug Products (OIPs): Workshop Summary Report.
Adams WP; Ahrens RC; Chen ML; Christopher D; Chowdhury BA; Conner DP; Dalby R; Fitzgerald K; Hendeles L; Hickey AJ; Hochhaus G; Laube BL; Lucas P; Lee SL; Lyapustina S; Li B; O'Connor D; Parikh N; Parkins DA; Peri P; Pitcairn GR; Riebe M; Roy P; Shah T; Singh GJ; Sharp SS; Suman JD; Weda M; Woodcock J; Yu L
J Aerosol Med Pulm Drug Deliv; 2010 Feb; 23(1):1-29. PubMed ID: 20131983
[TBL] [Abstract][Full Text] [Related]
11. Equivalence-by-design: targeting in vivo drug delivery profile.
Chen ML; Lee VH
Pharm Res; 2008 Dec; 25(12):2723-30. PubMed ID: 18956142
[TBL] [Abstract][Full Text] [Related]
12. The Global Bioequivalence Harmonization Initiative: Summary report for EUFEPS international conference.
Chen ML; Blume H; Beuerle G; Davit B; Mehta M; Potthast H; Schug B; Tsang YC; Wedemeyer RS; Weitschies W; Welink J
Eur J Pharm Sci; 2018 Jan; 111():153-157. PubMed ID: 28964950
[TBL] [Abstract][Full Text] [Related]
13. Quality and equivalence of topical products: A critical appraisal.
Miranda M; Cardoso C; Vitorino C
Eur J Pharm Sci; 2020 May; 148():105082. PubMed ID: 31626969
[TBL] [Abstract][Full Text] [Related]
14. Assuring quality and performance of sustained and controlled release parenterals: workshop report.
Burgess DJ; Hussain AS; Ingallinera TS; Chen ML
AAPS PharmSci; 2002; 4(2):E7. PubMed ID: 12141269
[TBL] [Abstract][Full Text] [Related]
15. Overview of Brazilian Requirements for Therapeutic Equivalence of Orally Inhaled and Nasal Drug Products.
Silva MC; Costa HS; Valadares BN; Grecchi L; Nagao L; Santos GML
AAPS PharmSciTech; 2019 Jun; 20(6):235. PubMed ID: 31236849
[TBL] [Abstract][Full Text] [Related]
16. The Global Bioequivalence Harmonisation Initiative (GBHI): Report of EUFEPS/AAPS fourth conference.
Hh B; M M; G B; A D; G H; W J; A K; J L; H P; B S; A S; N T; Tsang YC; J W; J W
Eur J Pharm Sci; 2021 Dec; 167():105987. PubMed ID: 34481066
[TBL] [Abstract][Full Text] [Related]
17. Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective.
Chen ML
Adv Drug Deliv Rev; 2008 Mar; 60(6):768-77. PubMed ID: 18077051
[TBL] [Abstract][Full Text] [Related]
18. Biowaiver for Immediate and Modified Release Dosage forms Scientific summary of the CSPS workshop.
Loebenberg R
J Pharm Pharm Sci; 2020; 23():. PubMed ID: 32877636
[TBL] [Abstract][Full Text] [Related]
19. Assuring quality and performance of sustained and controlled release parenterals: EUFEPS workshop report.
Burgess DJ; Crommelin DJ; Hussain AS; Chen ML;
AAPS PharmSci; 2004 Mar; 6(1):E11. PubMed ID: 15198512
[TBL] [Abstract][Full Text] [Related]
20. Do regulatory bioequivalence requirements adequately reflect the therapeutic equivalence of modified-release drug products?
Endrenyi L; Tothfalusi L
J Pharm Pharm Sci; 2010 May; 13(1):107-13. PubMed ID: 20456835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
